PT - JOURNAL ARTICLE AU - Davido, Benjamin AU - Lansaman, Thibaud AU - Lawrence, Christine AU - Alvarez, Jean-Claude AU - Bouchand, Frédérique AU - Moine, Pierre AU - Perronne, Véronique AU - Gal, Aurelie Le AU - Annane, Djillali AU - Perronne, Christian AU - De Truchis, Pierre AU - , TI - Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)? AID - 10.1101/2020.05.05.20088757 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.05.20088757 4099 - http://medrxiv.org/content/early/2020/05/20/2020.05.05.20088757.short 4100 - http://medrxiv.org/content/early/2020/05/20/2020.05.05.20088757.full AB - “The authors have withdrawn this manuscript and do not wish it to be cited. Because of controversy about hydroxychloroquine and the retrospective nature of their study, they intend to revise the manuscript after peer review”Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04364698Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available for the journal editor on request.